1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/12/2024 | XYL | Buy Now | Xylem | $127.49 | 17.66% | Exane BNP Paribas | Andrew Buscaglia | → $150 | Initiates | → Outperform | Get Alert |
02/07/2024 | XYL | Buy Now | Xylem | $127.49 | 17.66% | Stifel | Nathan Jones | $136 → $150 | Maintains | Buy | Get Alert |
02/07/2024 | XYL | Buy Now | Xylem | $127.49 | -1.17% | Citigroup | Andrew Kaplowitz | $122 → $126 | Maintains | Neutral | Get Alert |
02/07/2024 | XYL | Buy Now | Xylem | $127.49 | 13.73% | RBC Capital | Deane Dray | $140 → $145 | Maintains | Outperform | Get Alert |
01/04/2024 | XYL | Buy Now | Xylem | $127.49 | 9.81% | RBC Capital | Deane Dray | $120 → $140 | Maintains | Outperform | Get Alert |
12/19/2023 | XYL | Buy Now | Xylem | $127.49 | 6.68% | Stifel | Nathan Jones | $133 → $136 | Maintains | Buy | Get Alert |
12/13/2023 | XYL | Buy Now | Xylem | $127.49 | -0.38% | Wolfe Research | Brad Hewitt | → $127 | Initiates | → Outperform | Get Alert |
12/11/2023 | XYL | Buy Now | Xylem | $127.49 | -14.5% | Citigroup | Andrew Kaplowitz | $104 → $109 | Maintains | Neutral | Get Alert |
11/21/2023 | XYL | Buy Now | Xylem | $127.49 | -5.87% | Deutsche Bank | Andy Krill | $104 → $120 | Upgrade | Hold → Buy | Get Alert |
11/01/2023 | XYL | Buy Now | Xylem | $127.49 | -18.42% | Citigroup | Andrew Kaplowitz | $101 → $104 | Maintains | Neutral | Get Alert |
11/01/2023 | XYL | Buy Now | Xylem | $127.49 | -5.87% | RBC Capital | Deane Dray | $123 → $120 | Maintains | Outperform | Get Alert |
10/19/2023 | XYL | Buy Now | Xylem | $127.49 | -7.44% | Oppenheimer | Bryan Blair | → $118 | Upgrade | Perform → Outperform | Get Alert |
10/09/2023 | XYL | Buy Now | Xylem | $127.49 | -20.78% | Citigroup | Andrew Kaplowitz | $125 → $101 | Maintains | Neutral | Get Alert |
10/02/2023 | XYL | Buy Now | Xylem | $127.49 | -4.31% | Melius Research | Scott Davis | → $122 | Upgrade | Hold → Buy | Get Alert |
08/29/2023 | XYL | Buy Now | Xylem | $127.49 | — | Seaport Global | Scott Graham | — | Initiates | → Neutral | Get Alert |
08/03/2023 | XYL | Buy Now | Xylem | $127.49 | 1.18% | RBC Capital | Deane Dray | $133 → $129 | Maintains | Outperform | Get Alert |
06/29/2023 | XYL | Buy Now | Xylem | $127.49 | -5.09% | Deutsche Bank | Andy Krill | → $121 | Initiates | → Hold | Get Alert |
06/08/2023 | XYL | Buy Now | Xylem | $127.49 | 4.32% | Goldman Sachs | Brian Lee | → $133 | Reinstates | → Buy | Get Alert |
05/31/2023 | XYL | Buy Now | Xylem | $127.49 | 5.89% | Baird | Michael Halloran | $122 → $135 | Upgrade | Neutral → Outperform | Get Alert |
The latest price target for Xylem (NYSE: XYL) was reported by Exane BNP Paribas on March 12, 2024. The analyst firm set a price target for $150.00 expecting XYL to rise to within 12 months (a possible 17.66% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Xylem (NYSE: XYL) was provided by Exane BNP Paribas, and Xylem initiated their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xylem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xylem was filed on March 12, 2024 so you should expect the next rating to be made available sometime around March 12, 2025.
While ratings are subjective and will change, the latest Xylem (XYL) rating was a initiated with a price target of $0.00 to $150.00. The current price Xylem (XYL) is trading at is $127.49, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.